New agents for the treatment of acute lymphoblastic leukemia:
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY [u.a.]
Springer
2011
|
Schlagworte: | |
Online-Zugang: | DE-703 Volltext |
Beschreibung: | 1 Online-Ressource |
ISBN: | 9781441984593 |
DOI: | 10.1007/978-1-4419-8459-3 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV039887434 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 120214s2011 xx o|||| 00||| eng d | ||
020 | |a 9781441984593 |c Online |9 978-1-4419-8459-3 | ||
024 | 7 | |a 10.1007/978-1-4419-8459-3 |2 doi | |
035 | |a (OCoLC)752226786 | ||
035 | |a (DE-599)BVBBV039887434 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-703 | ||
084 | |a YC 2515 |0 (DE-625)153202:12921 |2 rvk | ||
245 | 1 | 0 | |a New agents for the treatment of acute lymphoblastic leukemia |c Vaskar Saha ; Pamela Kearns, ed. |
264 | 1 | |a New York, NY [u.a.] |b Springer |c 2011 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Akute lymphatische Leukämie |0 (DE-588)4221958-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Lymphatische Leukämie |0 (DE-588)4221960-7 |2 gnd |9 rswk-swf |
653 | |a Leukemia | ||
653 | |a Precursor Cell Lymphoblastic Leukemia-Lymphoma |a drug therapy | ||
653 | |a Adolescent | ||
653 | |a Antineoplastic Agents |a therapeutic use | ||
653 | |a Child | ||
653 | |a Clinical Trials as Topic | ||
653 | |a Treatment Outcome | ||
689 | 0 | 0 | |a Lymphatische Leukämie |0 (DE-588)4221960-7 |D s |
689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 0 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Akute lymphatische Leukämie |0 (DE-588)4221958-9 |D s |
689 | 1 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 1 | |8 1\p |5 DE-604 | |
700 | 1 | |a Saha, Vaskar |e Sonstige |4 oth | |
700 | 1 | |a Kearns, Pamela |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-4419-8458-6 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4419-8459-3 |x Verlag |3 Volltext |
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
912 | |a ZDB-2-SBL | ||
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-024746522 | |
966 | e | |u https://doi.org/10.1007/978-1-4419-8459-3 |l DE-703 |p ZDB-2-SBL |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1817529945819185152 |
---|---|
adam_text | |
any_adam_object | |
building | Verbundindex |
bvnumber | BV039887434 |
classification_rvk | YC 2515 |
collection | ZDB-2-SBL |
ctrlnum | (OCoLC)752226786 (DE-599)BVBBV039887434 |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-4419-8459-3 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV039887434</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">120214s2011 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781441984593</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4419-8459-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4419-8459-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)752226786</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039887434</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 2515</subfield><subfield code="0">(DE-625)153202:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New agents for the treatment of acute lymphoblastic leukemia</subfield><subfield code="c">Vaskar Saha ; Pamela Kearns, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Akute lymphatische Leukämie</subfield><subfield code="0">(DE-588)4221958-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lymphatische Leukämie</subfield><subfield code="0">(DE-588)4221960-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Leukemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Precursor Cell Lymphoblastic Leukemia-Lymphoma</subfield><subfield code="a">drug therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Adolescent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antineoplastic Agents</subfield><subfield code="a">therapeutic use</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Child</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Clinical Trials as Topic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Treatment Outcome</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lymphatische Leukämie</subfield><subfield code="0">(DE-588)4221960-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Akute lymphatische Leukämie</subfield><subfield code="0">(DE-588)4221958-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saha, Vaskar</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kearns, Pamela</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-4419-8458-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4419-8459-3</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024746522</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4419-8459-3</subfield><subfield code="l">DE-703</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV039887434 |
illustrated | Not Illustrated |
indexdate | 2024-12-04T17:00:28Z |
institution | BVB |
isbn | 9781441984593 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024746522 |
oclc_num | 752226786 |
open_access_boolean | |
owner | DE-703 |
owner_facet | DE-703 |
physical | 1 Online-Ressource |
psigel | ZDB-2-SBL |
publishDate | 2011 |
publishDateSearch | 2011 |
publishDateSort | 2011 |
publisher | Springer |
record_format | marc |
spelling | New agents for the treatment of acute lymphoblastic leukemia Vaskar Saha ; Pamela Kearns, ed. New York, NY [u.a.] Springer 2011 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Akute lymphatische Leukämie (DE-588)4221958-9 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Lymphatische Leukämie (DE-588)4221960-7 gnd rswk-swf Leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy Adolescent Antineoplastic Agents therapeutic use Child Clinical Trials as Topic Treatment Outcome Lymphatische Leukämie (DE-588)4221960-7 s Pharmakotherapie (DE-588)4076066-2 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Akute lymphatische Leukämie (DE-588)4221958-9 s Therapie (DE-588)4059798-2 s 1\p DE-604 Saha, Vaskar Sonstige oth Kearns, Pamela Sonstige oth Erscheint auch als Druckausgabe 978-1-4419-8458-6 https://doi.org/10.1007/978-1-4419-8459-3 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | New agents for the treatment of acute lymphoblastic leukemia Arzneimittelentwicklung (DE-588)4143176-5 gnd Pharmakotherapie (DE-588)4076066-2 gnd Akute lymphatische Leukämie (DE-588)4221958-9 gnd Therapie (DE-588)4059798-2 gnd Lymphatische Leukämie (DE-588)4221960-7 gnd |
subject_GND | (DE-588)4143176-5 (DE-588)4076066-2 (DE-588)4221958-9 (DE-588)4059798-2 (DE-588)4221960-7 |
title | New agents for the treatment of acute lymphoblastic leukemia |
title_auth | New agents for the treatment of acute lymphoblastic leukemia |
title_exact_search | New agents for the treatment of acute lymphoblastic leukemia |
title_full | New agents for the treatment of acute lymphoblastic leukemia Vaskar Saha ; Pamela Kearns, ed. |
title_fullStr | New agents for the treatment of acute lymphoblastic leukemia Vaskar Saha ; Pamela Kearns, ed. |
title_full_unstemmed | New agents for the treatment of acute lymphoblastic leukemia Vaskar Saha ; Pamela Kearns, ed. |
title_short | New agents for the treatment of acute lymphoblastic leukemia |
title_sort | new agents for the treatment of acute lymphoblastic leukemia |
topic | Arzneimittelentwicklung (DE-588)4143176-5 gnd Pharmakotherapie (DE-588)4076066-2 gnd Akute lymphatische Leukämie (DE-588)4221958-9 gnd Therapie (DE-588)4059798-2 gnd Lymphatische Leukämie (DE-588)4221960-7 gnd |
topic_facet | Arzneimittelentwicklung Pharmakotherapie Akute lymphatische Leukämie Therapie Lymphatische Leukämie |
url | https://doi.org/10.1007/978-1-4419-8459-3 |
work_keys_str_mv | AT sahavaskar newagentsforthetreatmentofacutelymphoblasticleukemia AT kearnspamela newagentsforthetreatmentofacutelymphoblasticleukemia |